Ritu Salani, MD

Ritu Salani, MD, MBA

Professor, Department of Obstetrics and Gynecology
Member, JCCC Community





Gynecology/Obstetrics, Emory University School of Medicine, Atlanta, GA, 2005
Gynecologic Oncology (Gyn Onc), Johns Hopkins University School of Medicine, Baltimore, MD, 2008


MBA, Johns Hopkins Carey Business School, Baltimore, MD, 2008
MD, Northeastern Ohio Universities College of Medicine (NEOUCOM), Rootstown, OH, 2001
BS, Kent State University, Kent, OH, 1997


Obstetrics & Gynecology, Emory University School of Medicine, 2005

Board Certifications

Gynecologic Oncology, American Board of Obstetrics and Gynecology, 2012
Obstetrics and Gynecology, American Board of Obstetrics and Gynecology, 2010

Contact Information

Scientific Interests

Dr. Salani's research is focused on identifying novel therapies for advanced and recurrent cervical cancer with an emphasis on immunotherapy. Currently, she is the Principal Investigator of a trial evaluating the role of immunotherapy in combination with chemoradiation for advanced cervical cancer as well as trial of a novel combination of immunotherapy in recurrent cervical cancer. She is also focused on optimizing best practices for surveillance after cancer treatment and improving patient centered outcomes during cancer treatment.

Highlighted Publications

Marsh LA, Aviki EM, Wright JD, Chen L, Abu-Rustum N, Salani R. Sentinel lymph node mapping for endometrial cancer: Opportunity for medical waste reform. Gynecol Oncol. 2022 Jul;166(1):162-164. doi: 10.1016/j.ygyno.2022.05.008. Epub 2022 May 18. PMID: 35597685.

Smrz SA, Calo C, Fisher JL, Salani R. An ecological evaluation of the increasing incidence of endometrial cancer and the obesity epidemic. Am J Obstet Gynecol. 2021 May;224(5):506.e1-506.e8. doi: 10.1016/j.ajog.2020.10.042. Epub 2020 Oct 27. PMID: 33127429.

DeMari J, Vetter MH, Chandra S, Hays JL, Salani R. Practice patterns in post-treatment surveillance in patients with primary epithelial ovarian cancer. Int J Gynecol Cancer. 2021 Jun;31(6):888-892. doi: 10.1136/ijgc-2020-001522. Epub 2020 Aug 5. PMID: 32759182.

Teoh D, Musa F, Salani R, Huh W, Jimenez E. Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations. Obstet Gynecol. 2020 Apr;135(4):869-878. doi: 10.1097/AOG.0000000000003761. PMID: 32168211; PMCID: PMC7098444.

Randall ME, Filiaci V, McMeekin DS, von Gruenigen V, Huang H, Yashar CM, Mannel RS, Kim JW, Salani R, DiSilvestro PA, Burke JJ, Rutherford T, Spirtos NM, Terada K, Anderson PR, Brewster WR, Small W, Aghajanian CA, Miller DS. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer. J Clin Oncol. 2019 Jul 20;37(21):1810-1818. doi: 10.1200/JCO.18.01575. Epub 2019 Apr 17. PMID: 30995174; PMCID: PMC6804858.